Skip to content

Aura Biosciences, Inc.

AURA

CIK 0001501796

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$114.32M
−22.2% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.92
−0.6% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$94.6M
Q1 May 2026
Cash
$84.79M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
103.39M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings